PRECIPIO, INC. Dividends, Preferred Stock, Cash
PRECIPIO, INC. (PRPO) reported Dividends, Preferred Stock, Cash of $4.47 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-04-13.
Discontinued › Shareholders' Equity › Dividends › Dividends, Preferred Stock
us-gaap:DividendsPreferredStockCash · last filed 2018-04-13
- PRECIPIO, INC. dividends, preferred stock, cash for the quarter ending 2016-12-31 was $0.00.
- PRECIPIO, INC. dividends, preferred stock, cash for the quarter ending 2016-09-30 was $0.00.
- PRECIPIO, INC. dividends, preferred stock, cash for the quarter ending 2015-06-30 was -$3.46M, a 1234.75% decline year-over-year.
- PRECIPIO, INC. dividends, preferred stock, cash for the quarter ending 2015-03-31 was $331.00K, a 43.91% increase year-over-year.
- PRECIPIO, INC. dividends, preferred stock, cash for fiscal 2016 was $4.47M.
- PRECIPIO, INC. dividends, preferred stock, cash for fiscal 2015 was -$3.13M, a 373.60% decline from fiscal 2014.
- PRECIPIO, INC. dividends, preferred stock, cash for fiscal 2014 was $1.14M, a 57.58% increase from fiscal 2013.
- PRECIPIO, INC. dividends, preferred stock, cash for fiscal 2013 was $726.00K, a 10.00% increase from fiscal 2012.
| Period end | Dividends, Preferred Stock, Cash 1 month | Dividends, Preferred Stock, Cash 3 month | Dividends, Preferred Stock, Cash 6 month | Dividends, Preferred Stock, Cash 9 month | Dividends, Preferred Stock, Cash 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $0.00 derived: sum of 2 quarters · filed 2017-04-13 | $4.47M 10-K · filed 2017-04-13 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $4.47M 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | $4.47M 10-Q · filed 2016-08-15 | ||||
| 2016-03-31 | $432.72K 10-K · filed 2018-04-13 | ||||
| 2015-12-31 | -$3.13M 10-K · filed 2017-04-13 | ||||
| 2015-06-30 | -$3.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$3.13M 10-Q · filed 2015-08-14 | -$2.83M derived: sum of 3 quarters · filed 2016-04-14 | -$2.52M derived: sum of 4 quarters · filed 2016-04-14 | |
| 2015-03-31 | $331.00K 10-Q · filed 2015-05-14 | $636.00K derived: sum of 2 quarters · filed 2016-04-14 | $940.00K derived: sum of 3 quarters · filed 2016-04-14 | $1.25M derived: sum of 4 quarters · filed 2016-04-14 | |
| 2014-12-31 | $305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $609.00K derived: sum of 2 quarters · filed 2016-04-14 | $914.00K derived: sum of 3 quarters · filed 2016-04-14 | $1.14M 10-K · filed 2016-04-14 | |
| 2014-09-30 | $304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $609.00K derived: sum of 2 quarters · filed 2014-11-12 | $839.00K 10-Q · filed 2014-11-12 | $1.02M derived: sum of 4 quarters · filed 2015-04-15 | |
| 2014-06-30 | $305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $535.00K 10-Q · filed 2014-08-08 | $717.00K derived: sum of 3 quarters · filed 2015-04-15 | $899.00K derived: sum of 4 quarters · filed 2015-04-15 | |
| 2014-03-31 | $230.00K 10-Q · filed 2014-05-15 | $412.00K derived: sum of 2 quarters · filed 2015-04-15 | $594.00K derived: sum of 3 quarters · filed 2015-04-15 | $775.00K derived: sum of 4 quarters · filed 2015-04-15 | |
| 2013-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $364.00K derived: sum of 2 quarters · filed 2015-04-15 | $545.00K derived: sum of 3 quarters · filed 2015-04-15 | $726.00K 10-K · filed 2015-04-15 | |
| 2013-09-30 | $182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $363.00K derived: sum of 2 quarters · filed 2013-11-14 | $544.00K 10-Q · filed 2013-11-14 | $709.00K derived: sum of 4 quarters · filed 2015-04-15 | |
| 2013-06-30 | $181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $362.00K 10-Q · filed 2013-08-08 | $527.00K derived: sum of 3 quarters · filed 2015-04-15 | $692.00K derived: sum of 4 quarters · filed 2015-04-15 | |
| 2013-03-31 | $181.00K 10-Q · filed 2013-05-09 | $346.00K derived: sum of 2 quarters · filed 2015-04-15 | $511.00K derived: sum of 3 quarters · filed 2015-04-15 | $676.00K derived: sum of 4 quarters · filed 2015-04-15 | |
| 2012-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $330.00K derived: sum of 2 quarters · filed 2015-04-15 | $495.00K derived: sum of 3 quarters · filed 2015-04-15 | $660.00K 10-K · filed 2015-04-15 | |
| 2012-09-30 | $165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $330.00K derived: sum of 2 quarters · filed 2012-11-08 | $495.00K 10-Q · filed 2012-11-08 | $645.00K derived: sum of 4 quarters · filed 2014-03-27 | |
| 2012-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $330.00K 10-Q · filed 2012-08-02 | $480.00K derived: sum of 3 quarters · filed 2014-03-27 | $630.00K derived: sum of 4 quarters · filed 2014-03-27 | |
| 2012-03-31 | $165.00K 10-Q · filed 2012-05-09 | $315.00K derived: sum of 2 quarters · filed 2014-03-27 | $465.00K derived: sum of 3 quarters · filed 2014-03-27 | ||
| 2011-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $300.00K derived: sum of 2 quarters · filed 2014-03-27 | $600.00K 10-K · filed 2014-03-27 | ||
| 2011-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $450.00K 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | $300.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |